← The Wire
ARTVNasdaq
Artiva Biotherapeutics, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1817241
Develops off-the-shelf NK cell therapies for blood cancers and solid tumors
red 8-K · 90d
$415M
Market cap
$9.58
Last close
-0.4%
1D
+2.4%
5D
447K
Volume
Price · last 39 sessions-15.1%
May 4L $6.80 · H $12.52Jun 29
43
Total filings
May 19, 2026
Last filing
12/31
Fiscal year end
SC 13D/ASC 13D/AJun 15, 2026SC 13D/ASC 13D/AMay 28, 20268-KExecutive ChangeMay 19, 2026SC 13D/ASC 13D/AMay 13, 20268-KCompany UpdateMay 8, 2026424B5424B5May 8, 202610-Q10-QMay 8, 20268-KResults of Operations · Reg FD DisclosureMay 8, 202610-K/A10-K/AApr 30, 202610-K10-KMar 10, 20268-KResults of OperationsMar 10, 20268-KExecutive ChangeFeb 24, 20268-KExecutive ChangeFeb 19, 20268-KExecutive ChangeDec 12, 20258-KReg FD Disclosure · Company UpdateNov 12, 202510-Q10-QNov 12, 20258-KResults of OperationsNov 12, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KExecutive Change · Shareholder VoteJun 25, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 202510-K10-KMar 24, 20258-KResults of OperationsMar 24, 20258-KExecutive ChangeJan 29, 202510-Q10-QNov 12, 20248-KResults of OperationsNov 12, 20248-KExecutive ChangeOct 22, 202410-Q10-QAug 29, 20248-KResults of OperationsAug 29, 2024SC 13GSC 13GAug 1, 2024SC 13GSC 13GAug 1, 2024SC 13GSC 13GAug 1, 2024SC 13DSC 13DJul 29, 2024SC 13DSC 13DJul 29, 20248-KBylaw AmendmentJul 22, 2024424B4424B4Jul 22, 2024S-1/AS-1/AJul 15, 2024S-1S-1Jun 28, 2024S-1/AS-1/AJun 6, 2022S-1/AS-1/AMar 7, 2022S-1/AS-1/AJan 21, 2022S-1/AS-1/ADec 16, 2021S-1S-1Apr 8, 2021
Insider Activity
In the 90 days to Dec 15, 2025: 1 sold $194K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 15, 2025 | Aslan FredPresident and CEO | Sell | 3,187 | $6.00 | $19K |
| Nov 17, 2025 | Aslan FredPresident and CEO | Sell | 6,375 | $3.38 | $22K |
| Oct 17, 2025 | Aslan FredPresident and CEO | Sell | 25,500 | $6.00 | $153K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance